• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意义未明单克隆丙种球蛋白病中拷贝数改变的全基因组分析。

Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.

作者信息

Mikulasova Aneta, Smetana Jan, Wayhelova Marketa, Janyskova Helena, Sandecka Viera, Kufova Zuzana, Almasi Martina, Jarkovsky Jiri, Gregora Evzen, Kessler Petr, Wrobel Marek, Walker Brian A, Wardell Christopher P, Morgan Gareth J, Hajek Roman, Kuglik Petr

机构信息

Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.

Department of Medical Genetics, University Hospital Brno, Brno, Czech Republic.

出版信息

Eur J Haematol. 2016 Dec;97(6):568-575. doi: 10.1111/ejh.12774. Epub 2016 Jun 9.

DOI:10.1111/ejh.12774
PMID:27157252
Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is a benign condition with an approximate 1% annual risk of symptomatic plasma cell disorder development, mostly to multiple myeloma (MM). We performed genomewide screening of copy-number alterations (CNAs) in 90 MGUS and 33 MM patients using high-density DNA microarrays. We identified CNAs in a smaller proportion of MGUS (65.6%) than in MM (100.0%, P = 1.31 × 10 ) and showed median number of CNAs is lower in MGUS (3, range 0-22) than in MM (13, range 4-38, P = 1.82 × 10 ). In the MGUS cohort, the most frequent losses were located at 1p (5.6%), 6q (6.7%), 13q (30.0%), 14q (14.4%), 16q (8.9%), 21q (5.6%), and gains at 1q (23.3%), 2p (6.7%), 6p (13.3%), and Xq (7.8%). Hyperdiploidy was detected in 38.9% of MGUS cases, and the most frequent whole chromosome gains were 3 (25.6%), 5 (23.3%), 9 (37.8%), 15 (23.3%), and 19 (32.2%). We also identified CNAs such as 1p, 6q, 8p, 12p, 13q, 16q losses, 1q gain and hypodiploidy, which are potentially associated with an adverse prognosis in MGUS. In summary, we showed that MGUS is similar to MM in that it is a genetically heterogeneous disorder, but overall cytogenetic instability is lower than in MM, which confirms that genetic abnormalities play important role in monoclonal gammopathies.

摘要

意义未明的单克隆丙种球蛋白病(MGUS)是一种良性疾病,每年有大约1%的风险发展为有症状的浆细胞疾病,主要是多发性骨髓瘤(MM)。我们使用高密度DNA微阵列对90例MGUS患者和33例MM患者进行了全基因组拷贝数改变(CNA)筛查。我们发现MGUS患者中CNA的比例(65.6%)低于MM患者(100.0%,P = 1.31×10),且MGUS患者的CNA中位数(3,范围0 - 22)低于MM患者(13,范围4 - 38,P = 1.82×10)。在MGUS队列中,最常见的缺失位于1p(5.6%)、6q(6.7%)、13q(30.0%)、14q(14.4%)、16q(8.9%)、21q(5.6%),最常见的增益位于1q(23.3%)、2p(6.7%)、6p(13.3%)和Xq(7.8%)。在38.9%的MGUS病例中检测到超二倍体,最常见的全染色体增益是3(25.6%)、5(23.3%)、9(37.8%)、15(23.3%)和19(32.2%)。我们还发现了如1p、6q、8p、12p、13q、16q缺失、1q增益和亚二倍体等CNA,它们可能与MGUS的不良预后相关。总之,我们表明MGUS与MM相似,都是基因异质性疾病,但总体细胞遗传学不稳定性低于MM,这证实了基因异常在单克隆丙种球蛋白病中起重要作用。

相似文献

1
Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.意义未明单克隆丙种球蛋白病中拷贝数改变的全基因组分析。
Eur J Haematol. 2016 Dec;97(6):568-575. doi: 10.1111/ejh.12774. Epub 2016 Jun 9.
2
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy.单克隆丙种球蛋白病中拷贝数变异(CNV)的鉴定和监测。
Cancer Biol Ther. 2021 Jun 3;22(5-6):404-412. doi: 10.1080/15384047.2021.1946458. Epub 2021 Jul 21.
3
Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.浆细胞疾病患者中CKS1B mRNA表达及拷贝数增加的定量分析。
Blood Cells Mol Dis. 2014 Sep;53(3):110-7. doi: 10.1016/j.bcmd.2014.05.006. Epub 2014 Jun 25.
4
Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.超二倍体在意义未明的单克隆丙种球蛋白病中很常见,而13号染色体单体仅局限于这些超二倍体患者。
Clin Cancer Res. 2007 Oct 15;13(20):6026-31. doi: 10.1158/1078-0432.CCR-07-0031.
5
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.意义未明的单克隆丙种球蛋白血症中的体细胞突变谱表明其基因组图谱比多发性骨髓瘤更为简单。
Haematologica. 2017 Sep;102(9):1617-1625. doi: 10.3324/haematol.2017.163766. Epub 2017 May 26.
6
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status.基于 SNP 的图谱分析揭示了单克隆丙种球蛋白病(从 MGUS 到骨髓瘤状态)中的高基因组复杂性。
Leukemia. 2012 Dec;26(12):2521-9. doi: 10.1038/leu.2012.128. Epub 2012 May 8.
7
Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.意义未明的单克隆丙种球蛋白病与多发性骨髓瘤及浆细胞白血病中非整倍体模式的荧光原位杂交分析
Cancer. 2003 Feb 1;97(3):601-9. doi: 10.1002/cncr.11100.
8
Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.意义未明的单克隆丙种球蛋白病:当前概念与未来展望。
Curr Hematol Malig Rep. 2020 Apr;15(2):45-55. doi: 10.1007/s11899-020-00569-2.
9
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤的诊断、风险分层及管理
Int J Lab Hematol. 2016 May;38 Suppl 1:110-22. doi: 10.1111/ijlh.12504. Epub 2016 May 9.
10
Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).意义未明单克隆丙种球蛋白病的全基因组关联研究。
Eur J Haematol. 2017 Jul;99(1):70-79. doi: 10.1111/ejh.12892. Epub 2017 May 24.

引用本文的文献

1
Is It Possible to Predict Tumor Progression Through Genomic Characterization of Monoclonal Gammopathy and Smoldering Multiple Myeloma?是否可以通过单克隆丙种球蛋白病和冒烟型多发性骨髓瘤的基因组特征预测肿瘤进展?
Mediterr J Hematol Infect Dis. 2024 May 1;16(1):e2024044. doi: 10.4084/MJHID.2024.044. eCollection 2024.
2
BDL-SP: A Bio-inspired DL model for the identification of altered Signaling Pathways in Multiple Myeloma using WES data.BDL-SP:一种受生物启发的深度学习模型,用于利用全外显子测序(WES)数据识别多发性骨髓瘤中改变的信号通路。
Am J Cancer Res. 2023 Apr 15;13(4):1155-1187. eCollection 2023.
3
Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias.
浆细胞异常患者通过表型方法评估浆细胞与通过 NGS 检测的分子谱的相关性。
BMC Med Genomics. 2022 Sep 23;15(1):203. doi: 10.1186/s12920-022-01346-1.
4
Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic events.MGUS 的诊断、风险分层和管理进展:介绍骨髓瘤定义性基因组事件。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):662-672. doi: 10.1182/hematology.2021000303.
5
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.骨髓瘤小鼠模型的纵向单细胞分析确定了与进展相关的亚克隆分子程序。
Nat Commun. 2021 Nov 3;12(1):6322. doi: 10.1038/s41467-021-26598-w.
6
Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?冒烟型多发性骨髓瘤的基因组学:研究结果的临床转化时机到了吗?
Cancers (Basel). 2021 Jul 1;13(13):3319. doi: 10.3390/cancers13133319.
7
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.全基因组测序揭示进展性与稳定性骨髓瘤前体疾病是两种截然不同的实体。
Nat Commun. 2021 Mar 25;12(1):1861. doi: 10.1038/s41467-021-22140-0.
8
Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma.多发性骨髓瘤中1q21染色体臂的获得/扩增
Cancers (Basel). 2021 Jan 12;13(2):256. doi: 10.3390/cancers13020256.
9
The molecular pathogenesis of multiple myeloma.多发性骨髓瘤的分子发病机制。
Hematol Rep. 2020 Dec 18;12(3):9054. doi: 10.4081/hr.2020.9054. eCollection 2020 Dec 2.
10
A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity.多发性骨髓瘤的演变之旅:从正常浆细胞到疾病复杂性
Hemasphere. 2020 Nov 24;4(6):e502. doi: 10.1097/HS9.0000000000000502. eCollection 2020 Dec.